Analyst firms · Piper Sandler · STE

Piper Sandler STE price target and rating history

STERIS plc (Ireland) (STE) · Health Care

Piper Sandler rates STERIS plc (Ireland) (STE) Overweight with a $260 price target, as of its latest action on Oct 24, 2024. It has published 3 rating actions on STE since July 2022, including 1 upgrade and 1 downgrade.

Current rating
Overweight
Price target
$260
Median target, all firms
Too few
Actions on STE
3

Piper Sandler price target on STE

$260$229$1972023202420252026
Piper Sandler price target on STE, each point a stated target, July 2022 to October 2024.

Every Piper Sandler rating on STE

How other firms rate STE

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
JefferiesBuy$305Nov 13, 2026
UBSBuy$275Jul 28, 2026

Questions about Piper Sandler and STE

What is Piper Sandler's price target for STE?
Piper Sandler's latest stated price target for STERIS plc (Ireland) (STE) is $260, from its action on Oct 24, 2024.
What is Piper Sandler's rating on STE?
Piper Sandler rates STE Overweight, a bullish rating, as of Oct 24, 2024.
When did Piper Sandler last change its view on STE?
On Oct 24, 2024, Piper Sandler upgrades to Overweight from Neutral, price target $230 to $260.

More STE rating histories

All Piper Sandler ratingsSTE news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.